SCHEMBL8418048

SCHEMBL8418048

c1cnc(N2CCN(CCCCn3ccc4ccccc43)CC2)nc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.60
▸ DRD2 P14416 6/20 0.59
▸ DRD3 P35462 4/20 0.59
▸ DRD4 P21917 3/20 0.59
▸ P2RX7 Q99572 5/20 0.58
▸ CDK4 P11802 3/20 0.58
▸ CCND1 P24385 3/20 0.58
▸ ABCB1 P08183 1/20 0.57
▸ HTR1A P08908 6/20 0.54
▸ HTR2A P28223 5/20 0.51
▸ DRD1 P21728 1/20 0.51
▸ DRD5 P21918 1/20 0.51
▸ HTR7 P34969 4/20 0.51
▸ HTR6 P50406 3/20 0.50
▸ ABCB11 O95342 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ ADRA2B P18089 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3990196 0.80 CDK4 (0.73) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL4334478 0.79 CDK4 (0.67) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL11328649 0.79 SLC6A2 (0.54) SIGMAR1DRD2DRD3DRD4CDK4
SCHEMBL8418073 0.79 DRD2 (0.70) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL9776119 0.79 CDK4 (0.74) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL12124558 0.78 DRD2 (0.68) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL15748168 0.78 SIGMAR1 (0.70) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL15748138 0.78 DRD2 (0.68) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL8416344 0.78 P2RX7 (0.61) SIGMAR1DRD2DRD3DRD4P2RX7
SCHEMBL26492991 0.78 HTR1A (0.65) SIGMAR1DRD2DRD3DRD4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 — — EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 — — US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 — — EP claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 — — EP claimed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 — — EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 — — EP claimed
Send feedback